沙培林联合顺铂治疗恶性胸腔积液疗效观察  

Clinical Observation on Treatment Efficacy of Malignant Pleural Effusion by the use of Integrative OK-432 and Cisplatin.

作　　者：秦瑞纳 

机构地区：[1]山东省兖州市人民医院,272100

出　　处：《医学理论与实践》2005年第9期1015-1016,共2页The Journal of Medical Theory and Practice

摘　　要：目的:观察沙培林联合顺铂治疗恶性胸腔积液化气的疗效。方法:将收治的46例恶性胸水患者随机分为两组,治疗组23例采用沙培林加顺铂治疗;对照组23例单用顺铂治疗。结果:治疗组有效率86.9%,对照组有效率65.1%,治疗组的疗效明显好于对照组。结论:沙培林联合顺铂治疗恶性胸腔积液疗效好,毒副作用少,有较高临床应用价值。Objective：To observe the clinical effect of OK - 432 combining with eisplatin in treating malignant pleural ettusion. Methods：The 46 patients were randomly divided into two groups, the 23 patients of treated group were treated with OK- 432 and eisplafin, the 23 patients of control group were treated with only eisplatin. Results： The effective rate in the treated group were 86.9%, and in the control group were 65.1%, the therapeutic effect in the former was significantly superior to that in the latter. Conchusion： The therapeutic effect of OK- 432 combining with eisplation therapy is markedly effective for malignant pleural effusion, and the toxic reaction is lower. It has better clinical value.

关 键 词：沙培林 顺铂 恶性胸腔积液 

分 类 号：R730.58[医药卫生—肿瘤]